Physician profile
Scott B Floyd
NPI 1508249558
$7,179.10
in general payments reported to CMS, 2019-2025
20 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,622 · 2020: $1,335 · 2021: $1,979 · 2022: $939 · 2023: $142 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $3,439.50 | 2019-2021 | |
| Treace Medical Concepts, INC. | $1,491.63 | 2019-2025 | |
| Arthrosurface Incorporated | $1,003.21 | 2019 | |
| Stryker Corporation | $435.49 | 2019-2025 | Augment Injectable, Ortholoc 3di |
| Smith+Nephew, INC. | $219.76 | 2019-2022 | |
| Orthofix Medical, INC. | $145.04 | 2019-2022 | |
| Trice Medical, INC. | $79.00 | 2020 | |
| Integra Lifesciences Corporation | $61.24 | 2020 | |
| Cpm Medical Consultants, LLC | $48.71 | 2020-2021 | |
| Zyla Life Sciences, INC. | $48.66 | 2019-2020 | |
| Melinta Therapeutics, LLC | $38.71 | 2019-2021 | |
| Organogenesis INC. | $30.91 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $24.95 | 2022 | |
| Ermi LLC | $20.10 | 2019 | |
| Nabriva Therapeutics, Plc | $18.60 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.71 | 2022 | |
| Medtronic, INC. | $15.36 | 2023 | Closurefast |
| Kowa Pharmaceuticals America, INC. | $14.54 | 2023 | Seglentis |
| Cashflow Solutions, LLC | $14.10 | 2022 | |
| Merck Sharp & Dohme LLC | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Floyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.